<DOC>
	<DOCNO>NCT00939536</DOCNO>
	<brief_summary>- Objective : - To compare rate extent absorption Zolpidem Tablets 10mg : Test Product : Zolpidem Tablets 10mg manufactured Torrent Pharmaceuticals Limited , India Reference Product : Ambien® Tablets 10 mg ( Reference Listed Drug ) manufacture Sanofi- Synthelabo Inc. fast condition 24 healthy , adult , human subject . - Study Design : - Open label , randomize , two-period , two-treatment , two-sequence single dose crossover design .</brief_summary>
	<brief_title>Bioequivalence Study Torrent Pharmaceutical Ltd. 's Zolpidem Tartrate Tablets Under Fasted Conditions</brief_title>
	<detailed_description>Open label , randomize , two-period , two-treatment , two-sequence single dose</detailed_description>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>1 . Male female subject range 18 45 year age . 2 . Body weight within ± 15 % ideal weight relate height body frame accord Life Insurance Corporation ( LIC ) Chart . ( Appendix A ) 3 . Subjects normal finding determine baseline history , physical examination vital sign ( blood pressure , pulse rate , respiration rate body temperature ) 4 . Subjects normal finding determine hematological test , serum chemistry , urine analysis , ECG Xray . 5 . Willingness follow protocol requirement evidence write , informed consent . 6 . Agreeing , use medication ( prescription counter ) , include vitamin mineral 15 day prior study course study . 7 . No history presence significant alcoholism drug abuse past one year . 8 . Nonsmokers , ex smoker light smoker include . `` Light smoker define someone smoking 10 cigarette less per day , ex smoker someone completely stop smoke least 3 month . 1 . Requiring medication ailment include enzymemodifying drug Use drug know induce inhibit hepatic drug metabolism ( e.g.s , inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , omeprazole ; inhibitor : SSRIs , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) within 30 day prior administration study medication . 2 . Any medical surgical condition , might significantly interfere function gastrointestinal tract , bloodforming organ etc . 3 . History cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic disease . 4 . History psychiatric disorder history suicide attempt . 5 . Participation clinical drug study bioequivalence study 90 day prior present study . 6 . History malignancy serious disease . 7 . Refusal abstain food ten ( 10 ) hour prior study drug administration day study period four ( 4 ) additional hour , post dose . 8 . Refusal abstain water one ( 1 ) hour prior study drug administration day study period two ( 2 ) additional hour , post dosing . 9 . Any contraindication blood sampling . 10 . Refusal abstain smoke consumption tobacco product 24 hour dose last sample collection period . Habituation tobacco necessitate uninterrupted tobacco consumption . 11 . Use xanthinecontaining beverage food 48 hour prior drug dose . 12 . Blood donation 90 day prior commencement study . 13 . Subjects positive HIV test , HbsAg HepatitisC test . 14 . Known history allergic reaction zolpidem relate drug . 15 . History drug abuse past one year . 16 . Use prescription medication within 14 day prior administration study medication counter product ( include natural food supplement , vitamin , garlic supplement ) within 2 week prior administration study medication , except topical product without systemic absorption . 17 . Pregnant lactating woman . At time screening , prior enrollment , presence pregnancy confirm urine pregnancy test . Female subject confirm use birth control measure , date screening till completion second period study . Abstinence , barrier method ( condom , diaphragm , etc . ) acceptable . Use hormonal contraceptive either oral implant acceptable . 18 . Female subject whose menstruation cycle coincides study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>